InhaleRx Pens AU$38.5 Million Funding Agreement with Clendon Biotech Capital Pharmaceutical Investing
Cardiol Therapeutics to Advance CardiolRx into a Late-Stage Trial in Patients with Recurrent Pericarditis Geography
Novartis receives positive CHMP opinion for Kisqali® to help reduce risk of recurrence in people with HR+/HER2- early breast cancer Pharmaceutical Investing
Cardiol Therapeutics Files Preliminary Prospectus Supplement for Proposed Public Offering of Common Shares Geography
Knight Therapeutics Inc. places No. 397 on The Globe and Mail's sixth annual ranking of Canada's Top Growing Companies Pharmaceutical Investing
